Neudle.com: tumor necrosis factor inhibitor

Differential
(Click to cross reference)

abciximab

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

acyclovir

adalimumab

aducanumab

advances in neurology

adverse drug reaction

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anemia

angiitis, granulomatous of CNS

angiotensin-converting enzyme

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti Yo antibody

anti-amyloid therapy

antineutrophil cytoplasmic autoantibodies

area postrema syndrome

arteritides

arteritis, temporal

arteritis, temporal, recurrent

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection, CNS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

bone marrow transplantation

brachial plexus injury

brachial plexus neuropathy

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

cancer associated myopathy

cardiac surgery, neurologic complications with

cardiac transplantation

CAT scan, contrast enhanced, subepend.

CAT scan, emission, abnormal

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral cortex

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, secondary prevention

chairbound

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

cluster headache

cognition

coinfection

collapsin response mediator protein 5 IgG

comorbidities

complications

confusion

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum, lesion of

cost

cost effectiveness

cranial neuropathy

C-reactive protein, elevated

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental milestones, loss of

diabetes insipidus

diagnostic criteria

diarrhea

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

diurnal variation

dizziness

donanemab

DPPX, antibodies, encephalitis

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

electron microscopy

emotional lability

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, delayed

eosinophilia

epidemiology of neurology

episodic disorders

epistaxis

Epstein-Barr virus

Epstein-Barr virus, negative

eptinezumab

erenumab

etanercept

evidence-based research

extralimbic encephalitis

eye movement, painful

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

faciobrachial dystonic seizure

fluorescein angiography

fremanezumab

frexalimab

fumarate

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gangliosides

gender

giant cell arteritis

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

Guillain Barre syndrome

hallucination

hallucination, olfactory

headache

headache, children

headache, drug induced

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, treatment of

headache, unilateral

hearing loss

hemianopia

hemiplegia, progressive

hemoglobinuria

hemolysis

hemosiderosis of CNS, superficial

hepatic failure

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

herpes zoster

hiccoughs

highly active antiretroviral therapy

hippocampus

HLA

Hodgkin's disease

human immunodeficiency virus type 1

hydrocephalus

hypercalcemia

hyperekplexia

hypereosinophilic syndrome(HES)

hypersensitivity reaction

hypertension

hypertrophic intracranial pachymeningitis

hypoglycorrhachia

hyponatremia

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

internal carotid artery

intracerebral hemorrhage

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

lactic dehydrogenase(LDH)

laquinimod

lecanemab

leucine rich glioma inactivated 1 antibodies

leukoencephalopathy

leukoencephalopathy, toxic

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

lymphopenia

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, chronic

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental status, abnormal

mercaptopurine

mesial temporal lobe

methotrexate

microhemorrhage, intracerebral

microscopic polyangiitis

microsporidia

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

migraine

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

mimics

misdiagnosis

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, nodular enhancement

MRI, spinal cord, increased intramedullary cord signal

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle weakness, proximal

MuSK antibodies

mutism

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

natalizumab, discontinuation

necrotizing vasculitis

negative

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

nerve biopsy

neurexin-3 alpha antibodies

neurofibromatosis 2

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurolymphomatosis

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, vasculitic, systemic

nonsteroidal anti-inflammatory drug

nortriptyline

ocrelizumab

oculovestibular reflex

ofatumumab

old age, neurology of

ophelia syndrome

ophthalmoplegia

opisthotonus

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, toxic

oral contraceptives

pain

pain, abdominal

paraneoplastic cerebellar degeneration

parasitic infection

parasitic infection, CNS

paresthesias

paroxysmal nocturnal hemoglobinuria

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pituitary stalk, enlarged

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

pneumonia

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

pontine hemorrhage

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postpartum

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protozoan infection

psoriasis

psoriatic arthritis

psychiatric problems in neurologic disorders

pulmonary infiltrates

quadriparesis

quality of life

race

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rapidly fatal neurologic illness

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

remternetug

renal transplantation

respiratory failure

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

rimegepant

risk factors

risk stratification

risk-benefit assessment

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

shared decision making

shoulder, pain in

skin, lesions in neurologic disorders

sleep pathology and physiology

somnolence

speech disorder

speech disorder, childhood

spinal cord

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

stem cell transplantation

steroid

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff joints

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma

teratoma, ovarian

thalamus, lesion of

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tocilizumab

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

treatment of neurologic disorder

treatment resistant

tremor

trigeminovascular system

triptans

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

uveitis

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

vasculitides

vasculopathy

ventricular assist device

vomiting, intractable

walking, difficulty with

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

white matter disease

white matter disease, subcortical

workup

zilucoplan

Showing articles 150 to 200 of 6787 << Previous Next >>

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
Emerg Infect Dis 13:469-471, Meersseman, W.,et al, 2007

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006

Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005

Efficacy of TNF a Blockade in Cyclophosphamide Resistant Neuro-Behet Disease
JNNP 76:1733-1735, Ribi,C.,et al, 2005

Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004

Salvage Therapy for Primary CNS Lymphoma with a Combination of Rituximab and Temozolomide
Neurol 63:901-903, Enting,R.H.,et al, 2004

Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003

Cerebral Toxoplasmosis Following Etanercept Treatment for Idiophatic Pneumonia Syndrome after Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT)
Ann Hematol 82:649-653, Gonzalez-Vicent, M.,et al, 2003

Refractory Neurosarcoidosis Responding to Infliximab
Neurol 59:1660-1661, Pettersen,J.A.,et al, 2002

Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001

Synergistic Immunomod Effects of Interferon-Beta1b & Phosphodiesterase Inhib Pentoxifylline in Pts with Relapsing-Remit MS
Ann Neurol 44:27-34, 71998., Weber,F.,et al, 1998

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

Aseptic Meningitis Following Cardiac Transplantation:Clinical Characteristics & Relationship to Immunosuppressive Regimen
Neurol 41:249-252, Adair,J.C.,et al, 1991

Treatment of Guillain-Barre Syndrome with Anti-T Cell Monoclonal Antibodies
JNNP 54:51-54, Feasby,T.E., 1991

OKT3 Encephalopathy
Ann Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990

Neurotoxicity After Treatment with Muromonab-CD3
NEJM 323:487-488, Richards,J.M.,et al, 1990

Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989

Nosocomial Aseptic Meningitis Associated with Administration of OKT3
JAMA 259:2002-2005, Martin,M.A.,et al, 1988

Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988

Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988

Peripheral Neuropathy Associated with Monoclonal IgM Autoantibody
Ann Neurol 22:764-767, Steck,A.J.,et al, 1987

Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986

Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984

Diagnostic Importance of Immunological Markers in Lymphoma Involving the Central Nervous System
Ann Neurol 16:668-672, Ezrin-Waters,C.,et al, 1984

Showing articles 150 to 200 of 6787 << Previous Next >>